KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Debt Ratio (2016 - 2025)

Teva Pharmaceutical Industries' Debt Ratio history spans 17 years, with the latest figure at 0.41 for Q4 2025.

  • For the quarter ending Q4 2025, Debt Ratio fell 8.79% year-over-year to 0.41, compared with a TTM value of 0.41 through Dec 2025, down 8.79%, and an annual FY2025 reading of 0.41, down 8.79% over the prior year.
  • Debt Ratio for Q4 2025 was 0.41 at Teva Pharmaceutical Industries, down from 0.42 in the prior quarter.
  • The five-year high for Debt Ratio was 0.51 in Q2 2021, with the low at 0.41 in Q4 2025.
  • Average Debt Ratio over 5 years is 0.47, with a median of 0.48 recorded in 2023.
  • Year-over-year, Debt Ratio rose 8.07% in 2021 and then decreased 8.79% in 2025.
  • Tracing TEVA's Debt Ratio over 5 years: stood at 0.48 in 2021, then dropped by 0.3% to 0.48 in 2022, then dropped by 5.36% to 0.46 in 2023, then dropped by 0.87% to 0.45 in 2024, then decreased by 8.79% to 0.41 in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Debt Ratio are 0.41 (Q4 2025), 0.42 (Q3 2025), and 0.43 (Q2 2025).